$DOCN Cashflow Statement | Understand Stock

$DOCN

$106.39 +$6.86 (6.89%) Close

$DOCN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net income attributable to common stockholders
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Stock-based compensation
Provision for expected credit losses
Gain on extinguishment of debt, net
Deferred income taxes
Acquisition related compensation
Operating lease right-of-use assets and liabilities, net
Non-cash interest expense
Net accretion of discounts and amortization of premiums on investments
Impairment of certain long-lived assets
Revaluation of warrants
Release of VAT reserve
Other
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Deferred revenue
Other assets and liabilities

Net cash provided by operating activities
Investing activities
Capital expenditures - property and equipment
Capital expenditures - internal-use software
Acquisition of equipment under financing arrangements
Purchase of intangible assets
Cash paid for acquisition of businesses, net of cash acquired
Cash paid for asset acquisitions
Purchase of marketable securities
Sales of marketable securities
Maturities of marketable securities
Purchased interest on marketable securities
Proceeds from interest on marketable securities
Proceeds from sale of equipment
Net cash (used in) provided by investing activities
Financing activities
Proceeds from issuance of convertible notes, net of issuance costs
Repayment of capital leases
Repayment of notes payable
Proceeds from third-party secured financings
Repayment of term loan
Proceeds from issuance of term loan, net of issuance costs
Repayment of borrowings under revolving credit facility
Proceeds from borrowings under revolving credit facility, net of issuance costs
Payment of debt issuance costs
Proceeds related to issuance of common stock under equity incentive plan
Proceeds from issuance of common stock under employee stock purchase plan
Employee payroll taxes paid related to net settlement of equity awards
Proceeds from initial public offering, net of underwriting discounts and commissions and other offering costs
Proceeds from the issuance of convertible preferred stock, net of issuance costs
Proceeds from debt, net of issuance costs
2030 Convertible Notes
2025 Credit Facility
Purchases of capped calls related to 2030 Convertible Notes
Repayments of 2026 Convertible Notes including related costs
Proceeds from financing arrangements
Principal repayments of finance leases and financing arrangements
Repurchase and retirement of common stock including related costs
Repayment of seller’s note
Net cash used in financing activities

Effect of exchange rate changes on cash, cash equivalents, and restricted cash
(Decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning of period
Cash, cash equivalents and restricted cash - end of period
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for taxes, net of refunds
Operating cash flows paid for operating leases
Non-cash investing and financing activities:
Capitalized stock-based compensation
Property and equipment received but not yet paid, included in accounts payable and accrued other expenses
Seller financed equipment purchases
Issuance of common stock for acquisition
Debt issuance costs included in accounts payable and accrued liabilities
Operating right-of-use assets obtained in exchange for operating lease liabilities
Finance right-of-use assets obtained in exchange for finance lease liabilities

Comments